Syringes and Needles - Market Insights, Competitive Landscape, and Market Forecast - 2030

Syringes and Needles - Market Insights, Competitive Landscape, and Market Forecast - 2030

Syringes And Needles Market By Usage (Disposable And Reusable), By Type (Syringes [Standard Syringes, Insulin Syringes, Prefilled Flush Syringes, Leur-Lock Syringes, And Others] And Needles [Hypodermic Needles, Pen Needles, And Others]), By End-User (Hospitals, Speciality Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of infectious diseases and the growing focus on improving the safety, affordability, and usability of syringes and needles for end-users, among others

The global syringes and needles market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030. The demand for syringes and needles is primarily being boosted owing to key factors such as the increasing prevalence of infectious diseases such as HIV, typhoid, and others, rising incidences of epidemics and pandemics such as influenza, COVID-19, and the growing focus on improving the safety, affordability, and usability of syringes and needles for end-users, among other factors are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

Syringes And Needles Market Dynamics:

According to the World Health Organization (WHO) 2022, globally around 37.7 million people were suffering from human immunodeficiency virus (HIV) in the year 2020. The syringes and needles are employed in the collection of blood and other samples for diagnostic purposes. For instance, the diagnostic test for HIV detection such as the Nucleic Acid Test (NAT), involves a process where the blood is drawn from the vein using an appropriate syringe and needle and is tested for the presence of the virus.

Lifestyle-related disorders such as diabetes, require blood sugar level management through insulin syringes and other needle-free injections applicable. As per statistics by the IDF Diabetes Atlas (2023), 537 million adults (1 in 10) were living with diabetes in 2021. Insulin therapies in the form of timely insulin injections through syringes and needles help in the regulation of overall blood sugar levels, thus possibly reducing the chances of stroke, and heart attacks, among others.

Further, the rising incidences of epidemics and pandemics across the world are going to boost the market growth for syringes and needles, owing to the greater demand for vaccination doses to provide protection and induce immunity among the global population during the forecast period. For instance, as per WHO 2023, globally at the end of December 2022, around 2.77 million doses of COVID- 19 vaccine were administered across the globe.

All the above-stated factors and figures for the total number of vaccine doses have been administered through syringes and needles and shall be delivered in the same way in the future as well, thus increasing the overall demand for syringes and needles during the forecast period.

Hence, the increasing adoption of syringes and needles for diagnostic, treatment, and immunizing purposes, is thereby anticipated to propel the overall market growth of the syringes and needles market during the forecast period from 2023–2028.

The increasing product development activities for syringes and needles are further expected to aid in the growth of the global syringes and needles market. In June 2021, to prevent injuries, Hindustan Syringes and Medical Devices Ltd. introduced a single-use disposal safety needle; the single-use sterile needles, launched with the tagline ""taking care of those who take care of us,"" and are supposed to prevent healthcare personnel from the possibility of unintentional NSIs (Needle stick injury).

However, complications associated with the improper use of syringes and needles, risks of cross-contamination, and alternate delivery methods, among others may act as barriers to the syringes and needles market growth.

The COVID-19 pandemic had a positive impact on the overall market growth of syringes and needles as various clinical and research trials for vaccine discovery involved the use of syringes and needles. During the late stages of the coronavirus pandemic after the commercial launch of the first vaccination, large masses of people were immunized using vaccine doses administered through syringes and needles. The hospitals, clinics, and other medical facilities were overburdened with managing and administering vaccine doses to patients affected by COVID-19. Due to an alarming demand for syringes and needles during the COVID-19 pandemic and in times to come to deliver immunity and to protect patients from further pandemics and infections, the market demand for syringes and needles is expected to further growth in the upcoming years during the forecast period.

Syringes And Needles Market Segment Analysis:

Syringes and Needles Market by Usage (Disposable and Reusable), Type (Syringes [Standard Syringes, Insulin Syringes, Prefilled Flush Syringes, Leur-Lock Syringes, and Others] and Needles [Hypodermic Needles, Pen Needles, and Others]), End-User (Hospitals, Speciality Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the syringes and needles market, the pen needles category is expected to amass a significant revenue share in the year 2023. This can be attributed to the large patient population base associated with diabetes, advantages, along with the increasing product development activities such as product launches in the pen needles category during the given forecast period.

According to statistics by the IDF Diabetes Atlas Tenth edition (2021), the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The source further stated that more than 1.2 million children and adolescents (0-19 years) were living with type 1 diabetes in 2021. The presence of such a huge population of diabetes-affected individuals requires quality products for insulin delivery for diabetes management.

Though pen needles can be more expensive than a vial and syringe, they are more convenient, less painful, easily storable, and transportable. They essentially combine the vial and syringe, allowing greater dose accuracy and easier administration of doses.

Along with this, the growing focus of manufacturers on designing and developing new pen needles for insulin delivery is going to accelerate the demand for the same. For example, in May 2022, Roche Diabetes Care India launched ACCU-FINE, quality pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes. The makers of ACCU-CHEK aim to make the process of insulin delivery easier thereby leading to better diabetes management for diabetic people.

Therefore, the benefits associated with pen needles along with product launches would increase their demand in the market, which will drive the growth of the overall global syringes and needles market during the forecast period.

North America is expected to dominate the overall Syringes And Needles Market:

Among all the regions, North America is estimated to account for the largest share of the global Syringes and Needles market in the year 2023. This domination is due to factors such as the presence of a wide end-user patient base associated with cardiovascular diseases, diabetes, and others, rising research and development activities in the region, surging launch and approval of new devices is also driving the market growth of syringes and needles in North America.

As per statistics by the Centers for Disease Control and Prevention (2021), about 20.1 million adults aged 20 had coronary artery disease in 2021. The source further stated that coronary heart disease is the most common type of heart disease, killing 382,820 people in 2020. The diagnosis, therapies, and treatment for coronary heart disease require the use of syringes and needles. Also, according to the Diabetes Research Institute (2023), 37.3 million people, or 11.3% of the US population, were affected by diabetes in 2022. The source further stated that an estimated 28.7 million people – or 28.5% of the population had been diagnosed with diabetes in the same year, whereas nearly 8.5 million people had diabetes but were not diagnosed.

Thus, the increasing number of patients with cardiovascular, diabetes, and other diseases may increase the demand for syringes and needles for their diagnosis, treatment, and other associated procedures during the forecast period.

The product development activities and product approvals are further expected to drive the demand for syringes and needles in the region. For instance, in March 2023, Techdow USA Inc., a growing market leader, and vertically integrated generic injectables company, announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the US market.

Therefore, the interplay of all the above-mentioned factors is expected to drive the market growth for syringes and needles in the region during the forecast period from 2022-2027.

Syringes And Needles Market Key Players:

Some of the key market players operating in the syringes and needles market include Becton, Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Gerresheimer AG, ICU Medical, Inc., Cardinal Health, Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation, SCHOTT PHARMA AG & CO. KGAA, Catalent, Inc, DeRoyal Industries, Inc., Connecticut Hypodermics, Inc., Albert David Ltd, PharmaJet, CODAN Companies, Medtronic plc, VOGT MEDICAL, Lifelong Meditech Private Limited, Hi-Tech Syringes, F. Hoffmann-La Roche AG, and others.

Recent Developmental Activities in the Syringes And Needles Market:

In March 2023, Nexus Pharmaceuticals, Inc. announced that it received US Food and Drug Administration (FDA) approval for EMERPHED® (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available.

In September 2022, BD (Becton, Dickinson, and Company), a leading global medical technology company, introduced a next-generation glass pre-fillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity. The new BD Effivax Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.

In July 2021, Fresenius Kabi launched a ready-to-administer fentanyl product prefilled syringe. The 1-mL presentation is said to be unique in the U.S. market and is designed to cut waste and diversion by reducing the potential for errors. Fresenius eliminated assembly steps to streamline point-of-care preparation, reduce the potential for waste and make it easier for healthcare professionals to dispense the prescribed dose.

Key Takeaways from the Syringes And Needles Market Report Study

Market size analysis for current syringes and needles market size (2023), and market forecast for 6 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global Syringes and Needles Market.

Various opportunities available for the other competitor in the syringes and needles market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current syringes and needles market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for syringes and needles market growth in the coming future?

Target Audience who can be benefited from this Syringes And Needles Market Report Study

Syringes and needles products providers

Research organizations and consulting companies

Syringes and needles-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in syringes and needles

Various end-users who want to know more about the syringes and needles market and the latest technological developments in the syringes and needles market.

Frequently Asked Questions for the Syringes And Needles Market:

1. What are Syringes and Needles?

Syringes and needles are sterile medical supplies used to inject solutions into the body or remove secretions. A syringe is a calibrated glass or plastic cylinder with an opening that connects to a needle and a plunger at one end. The needle is a metal tube that is hollow and has a pointy tip. A syringe and needle may also be used to remove various body fluids, most frequently blood from veins or tissue fluid from swollen joints.

2. What is the market for Global Syringes and Needles?

The global syringes and needles market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Syringes and Needles market?

The demand for syringes and needles is primarily being boosted owing to key factors such as the increasing prevalence of infectious diseases such as malaria, typhoid, and others, rising incidences of epidemics and pandemics such as influenza, COVID-19, and the growing focus on improving the safety, affordability, and usability of syringes and needles for end-users, among other factors are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

4. Who are the key players operating in the global Syringes and Needles market?

Some of the key market players operating in the syringes and needles market include Becton, Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Gerresheimer AG, ICU Medical, Inc., Cardinal Health, Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation, SCHOTT PHARMA AG & CO. KGAA, Catalent, Inc, DeRoyal Industries, Inc., Connecticut Hypodermics, Inc., Albert David Ltd, PharmaJet, CODAN Companies, Medtronic plc, VOGT MEDICAL, Lifelong Meditech Private Limited, Hi-Tech Syringes, F. Hoffmann-La Roche AG, and others.

5. Which region has the highest share in the Syringes and Needles market?

North America is expected to dominate the overall Syringes and Needles market during the forecast period from 2024-2030. This domination is due to factors such as the presence of a wide end-user patient base associated with cardiovascular diseases, diabetes, and others, rising research and development activities in the region, surging launch and approval of new devices is also driving the market growth of syringes and needles in North America.